EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age-Related Effects of AT1 Receptor Antagonist Losartan on Cognitive Decline in Spontaneously Hypertensive Rats

Jana Tchekalarova iD, Petja Ivanova, Desislava Krushovlieva

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jana Tchekalarova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Behavioral Neurobiology, Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Losartan, Rats, Inbred SHR, Cognitive Dysfunction, Aging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, European Union-Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Both hypertension and aging are known to increase the vulnerability of the brain to neurovascular damage, resulting in cognitive impairment. The present study investigated the efficacy of the antihypertensive drug losartan on age- and hypertension-associated cognitive decline and the possible mechanism underlying its effect in spontaneously hypertensive rats (SHRs). Losartan was administered (10 mg/kg, i.p. for 19 days) to 3- and 14-month-old SHRs. Age-matched Wistar rats were used as controls. Working memory, short-term object recognition, and spatial memory were assessed using the Y-maze, object recognition test (ORT) and radial arm maze (RAM) test. The expression of markers associated with aging, oxidative stress, and memory-related signaling was assessed in the frontal cortex (FC) and hippocampus. Motor activity measured over 24 h was not different between groups. Middle-aged vehicle-treated SHRs showed poorer performance in spontaneous alternation behavior (SAB) and activity in the first Y-maze test than their younger counterparts, suggesting age-related reduced “decision making” and reactivity in a novel environment. Losartan improved the age- and hypertension-induced decline in short-term recognition and spatial memory measured in the ORT and the second Y-maze test, particularly in the middle-aged rats, but was ineffective in the young adult rats. Changes in memory and age-related markers such as cAMP response element-binding protein (CREB) and amyloid-β1–42 (Aβ1–42) and increased oxidative stress were observed in the hippocampus but not in the FC between young adult and middle-aged vehicle-treated SHRs. Losartan increased CREB expression while reducing Aβ1–42 levels and concomitant oxidative stress in middle-aged SHRs compared with vehicle-treated SHRs. In conclusion, our study highlights the complex interplay between hypertension, aging, and cognitive impairment. It suggests that there is a critical time window for therapeutic intervention with angiotensin II type 1 receptor blockers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LosartanRats, Inbred SHRCognitive DysfunctionAgingOxidative StressHypertensionMaze LearningAngiotensin II Type 1 Receptor BlockersAnimalsRatsMaleRats, WistarHippocampusSpatial MemoryCyclic AMP Response Element-Binding ProteinAntihypertensive Agents

Stichwörter der Autor:innen

Aβ1–42CREBaginglosartanoxidative stressrat

Substanzen

LosartanAngiotensin II Type 1 Receptor BlockersCyclic AMP Response Element-Binding ProteinAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Behavioral Neurobiology, Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
  • Department of Organic Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria.

ORCID-Profile: Jana Tchekalarova

Förderung

  • the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
  • European Union-Next Generation EU

Zitieren

APA

Tchekalarova, J., Ivanova, P., & Krushovlieva, D. (2024). Age-Related Effects of AT1 Receptor Antagonist Losartan on Cognitive Decline in Spontaneously Hypertensive Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137340

Vancouver

Tchekalarova J, Ivanova P, Krushovlieva D. Age-Related Effects of AT1 Receptor Antagonist Losartan on Cognitive Decline in Spontaneously Hypertensive Rats. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137340

BibTeX
@article{Tchekalarova2024,
  author = {Tchekalarova, Jana and Ivanova, Petja and Krushovlieva, Desislava},
  title = {Age-Related Effects of AT1 Receptor Antagonist Losartan on Cognitive Decline in Spontaneously Hypertensive Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137340}
}
Kostenlos starten →